Hatchtech Drug Patent Portfolio
Hatchtech owns 1 orange book drug protected by 5 US patents Given below is the list of Hatchtech's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10292389 | Pediculicidal composition | 17 Dec, 2034 | Active |
| US7812163 | Methods and compositions for controlling ectoparasites | 28 Oct, 2026 | Active |
| US8212038 | Methods and compositions for controlling ectoparasites | 16 Jul, 2024 | Expired |
| US9357783 | Methods and compositions for controlling ectoparasites | 16 Jul, 2024 | Expired |
| US9839631 | Methods and compositions for controlling ectoparasites | 16 Jul, 2024 | Expired |
Latest Legal Activities on Hatchtech's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Hatchtech.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 03 May, 2024 | US7812163 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 May, 2024 | US8212038 |
|
Email Notification
Critical
| 03 May, 2024 | US9357783 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 May, 2024 | US7812163 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 May, 2024 | US9357783 |
|
Email Notification
Critical
| 03 May, 2024 | US9839631 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 May, 2024 | US9839631 |
|
Email Notification
Critical
| 03 May, 2024 | US8212038 |
|
Email Notification
Critical
| 18 Apr, 2024 | US10292389 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 18 Apr, 2024 | US10292389 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 02 Apr, 2024 | US10292389 |
|
Email Notification
Critical
| 02 Apr, 2024 | US10292389 |
|
Patent Term Extension Certificate
Critical
| 11 Mar, 2024 | US7812163 |
|
Withdrawal of Application for PTE
Critical
| 07 Mar, 2024 | US8212038 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 03 Jan, 2024 | US8212038 |
Hatchtech's Family Patents
Hatchtech drugs have patent protection in a total of 16 countries. It's US patent count contributes only to 27.3% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Hatchtech Drug List
Given below is the complete list of Hatchtech's drugs and the patents protecting them.
1. Xeglyze
Xeglyze is protected by 5 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10292389 | Pediculicidal composition |
17 Dec, 2034
(10 years from now)
| Active |
| US7812163 | Methods and compositions for controlling ectoparasites |
28 Oct, 2026
(2 years from now)
| Active |
| US8212038 | Methods and compositions for controlling ectoparasites |
16 Jul, 2024
(2 months ago)
| Expired |
| US9357783 | Methods and compositions for controlling ectoparasites |
16 Jul, 2024
(2 months ago)
| Expired |
| US9839631 | Methods and compositions for controlling ectoparasites |
16 Jul, 2024
(2 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xeglyze's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List